India

Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending Sept 2023). The company has been ranked No. 1 with over 12 different classes of doctors (SMSRC Prescription Data). Sun Pharma’s branded generics business in India commands leading position in high-growth chronic therapies and strong positioning in the acute segment.

Sun Pharma India specialises in technically complex products, offering a comprehensive therapy basket, and owns 35 brands out of the top 300 pharmaceutical brands in India. The top 10 brands contribute about 18% of India revenues. The top therapeuticsegments which contribute significantly to the company’s revenue and market share are Neuro-Psychiatry (16%), Gastroenterelogy (12%), Anti-Infectives (11%), Diabetology (7%), and; Pain/Analgesics (8%) among others. The company’s growth is driven by a basket of brands and low product concentration. With over 12,500 strong sales force reaching around 600,000 doctors, the company has one of widest reaches to India’s medical fraternity for therapy focused marketing.